[1] Ding XW, Wu JH, Jiang CP. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy [J]. Life Sci,2010,86(17-18):631-637
[2] Ishikawa T,Nakagawa H.Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics
  [J]. J Exp Ther Oncol,2009,8(1):5-24
[3] Wang X, Wu X, Wang C, et al. Transcriptional suppression of breast cancer resistance protein (BCRP) by wild-type p53 through the NF-κB pathway in MCF-7 cells [J]. FEBS Lett,2010,584(15):3392-3397
[4] Yasuda S, Kobayashi M, Itagaki S, et al. Response of the ABCG2 promoter in T47D cells and BeWo cells to
  sex hormone treatment [J]. Mol Biol Rep,2009,36(7):1889-1896
[5] Wang H, Unadkat JD, Mao Q. Hormonal regulation of BCRP expression in human placental BeWo cells [J].
  Pharm Res,2008,25(2):444-452.
[6] Wang H, Zhou L, Gupta A, et al.Regulation of BCRP/ABCG2 expression by progesterone and 17beta- estradiol in human placental BeWo cells [J]. Am J Physiol Endocrinol Metab,2006,290(5):E798-807
[7] Martin CM, Ferdous A, Gallardo T, et al. Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells [J]. Circ Res,2008,102(9):1075-1081
[8] Hartz AM, Madole EK, Miller DS, et al. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein [J]. J Pharmacol Exp Ther,2010,334(2):467-476
[9] Imai Y, Ohmori K, Yasuda S, et al. Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase [J]. Cancer Sci,2009,100(6):1118-1127
[10]Balbuena J, Pachon G, Lopez-Torrents G, et al. ABCG2 is required to control the Sonic Hedgehog pathway in side population cells with stem-like properties[J]. Cytometry A, 2011,79A(9):672-683
[11]Mosaffa F, Lage H, Afshari JT, et al. Interleukin-1β and tumor necrosis factor-α increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX [J]. Inflamm Res,2009,58(10):669-676
[12]Porro A, Iraci N, Soverini S, et al. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells [J]. Mol Cancer Res, 2011,9(8):1054-1066
[13]Meyer SE, Hasenstein JR, Baktula A, et al. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival [J]. Am J Pathol,2010,177(3):1503-1513
[14]Bark H, Xu HD, Kim SH, et al. P-glycoprotein down-regulates expression of breast cancer resistance protein in a drug-free state [J]. FEBS Lett,2008,582(17):2595-2600
[15]Hamada S, Satoh K, Hirota M, et al. The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2 [J].J Cell Physiol,2012,227(2):729-738
[16]Ehata S, Johansson E, Katayama R, et al. Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells [J]. Oncogene,2011,30(14):1693-1705
[17]Liu X, Jing XY, Jin S, et al. Insulin suppresses the expression and function of breast cancer resistance protein in primary cultures of rat brain microvessel endothelial cells[J].Pharmacol Rep,2011,63(2):487- 493
[18]Tan KP, Wang B, Yang M, et al. Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2) [J]. Mol Pharmacol,2010,78(2):175-185
[19]Ryan KM, Ernst MK, Rice NR, et al. Role of NF-κB in p53-mediated programmed cell death[J].Nature, 2000, 404 (6780):892-897
[20]Benoit V, de Moraes E, Dar NA, et al. Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-κB[J]. Oncogene, 2006,25(42): 5708-5718
[21]路钊, 郑少鹏, 牛静, 等. BATF2/SARI通过抑制p53依赖的NF-κB转录活性诱导肿瘤细胞凋亡[J].中国生物化学与分子生物学报(Lu Zhao, Zheng Shao-Peng, Niu Jing, et al. BATF2/SARI induces tumor cell apoptosis by inhibiting p53-dependent NF-κB activity [J]. Chin J Biochem Mol Biol), 2011,27 (6): 524-532
[22]Webster GA, Perkins ND. Transcriptional cross talk between NF-κB and p53 [J]. Mol Cell Biol, 1999, 19(5):3485-3495